N@N

WEALTHMAKERS.COM Issues Bearish Research Reports on AEV, ALV, ANAC, DYAX, IDA, KTH

<div>April 24, 2013 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: AEGON N.V. 6.875% Perpetual Capital Securities (NYSE:AEV), Autoliv Inc (NYSE:ALV), Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Dyax Corp (NASDAQ:DYAX), IDACORP Inc (NYSE:IDA), Structured Products Corp. 8.0% CorporateBacked Trust Securities Certifi (NYSE:KTH)

<p>Click here to download each report:</p>

AEGON N.V. 6.875% Perpetual Capital Securities (NYSE:AEV): http://www.wealthmakers.com/ireport/24071 Autoliv Inc (NYSE:ALV): http://www.wealthmakers.com/ireport/23848 Anacor Pharmaceuticals Inc (NASDAQ:ANAC): http://www.wealthmakers.com/ireport/24060 Dyax Corp (NASDAQ:DYAX): http://www.wealthmakers.com/ireport/22549 IDACORP Inc (NYSE:IDA): http://www.wealthmakers.com/ireport/24079 Structured Products Corp. 8.0% CorporateBacked Trust Securities Certifi (NYSE:KTH): http://www.wealthmakers.com/ireport/23717

<p>WealthMakers is powered by WOPR (WealthMakers Online Predictive Research), www.wopronline.com , a network of statistical servers with unbridled computing power to analyze exactly what event ( technicals, fundamentals, earnings, seasonality, short squeeze, group rotation, chart patterns, insider buying/selling and multiple other factors) will move each stock, in which direction, to what % degree, in the specific amount of time and with what degree of probability. Based on IBMs work on Deep Blue (now called "Watson"), this powerful database technology matched with hundreds of data feeds and the ability to find patterns, that humans cannot, has the ability to do the work of hundreds or thousands of analysts without getting tired (24 hours per day / 7 days per week). Our unparalleled technology, trading algorithms and proprietary data generate confident predictions, with clear and concise objectives resulting in unique and innovative research reports that move markets and create exponential returns to our clients.</p>

Click here to LIKE us on Facebook:

<p>http://www.facebook.com/pages/WealthMakers-Ltd/165424826916060 </p>

Click here to FOLLOW us on Twitter:

<p>http://www.twitter.com/WealthMakersLtd </p>

Click here to access WealthMakers technology:

<p>http://www.wealthmakers.com/signup.html </p>

Users access these powerful research reports though the PowerTrader Matrix. The Matrix automatically scans through 14,000 stocks, 11 strategies and real-time price updates to find only those stocks that have multiple predictions, at the same time, in the same direction, with no conflicting predictions and the fundamental value of the stock is in-line with the direction of the trade. This powerful technology filters out the exact long/short trades that our trading network need to enter at the precise time and price that they should be entered and exited.

<p>To learn more click here: http://www.buyins.com/woprbrochure.pdf

WealthMakers Power Trader works because the Market Read strategies have a very high success rate. "accuracy", "average return" and "average # of days in trade" are tracked in real-time and documented at www.buyins.com/images/stats.pdf</p>

AEGON N.V. 6.875% Perpetual Capital Securities (NYSE:AEV) - AEGON N.V. provides life insurance, pension, and asset management products and services primarily in the Americas, Europe, and Asia. The company offers a range of life and protection products, including traditional, universal, endowment, term, employer, and whole life insurance products; and accidental death and dismemberment, critical illness, cancer treatment, disability, income protection, and long term care insurance. It also offers individual savings and retirement products, including fixed and variable annuity products, retail mutual funds, and mortgages; employer solutions and pensions comprising individual and group pensions, as well as 401(k) plans and similar products sponsored by or obtained through an employer; and general insurance products, including automotive, liability, fire protection, and household insurance. AEGON N.V. markets its products directly, as well as through various sales and distribution channels, including independent and career agents, financial planners, registered representatives, independent marketing organizations, banks, broker-dealers, benefit consulting firms, wirehouses, affinity groups, institutional partners, independent managing general agencies, specialized financial advisors, and the Internet. The company was founded in 1900 and is headquartered in The Hague, the Netherlands.

<p>Autoliv Inc (NYSE:ALV) - Autoliv, Inc., through its subsidiaries, engages in the development, manufacture, and supply of automotive safety systems to the automotive industry. The company offers a range of products, including modules and components for passenger and driver-side airbags, side-impact airbag protection systems, seatbelts, steering wheels, safety electronics, anti-whiplash systems, pedestrian protection systems, and child seats. It also provides night vision and camera vision systems, radars, pyrotechnic belt pretensioners, brake controllers, and other active safety systems. Autoliv markets its products to car manufacturers in Europe, the Americas, China, Japan, and the rest of Asia. The company was founded in 1953 and is headquartered in Stockholm, Sweden.</p>

Anacor Pharmaceuticals Inc (NASDAQ:ANAC) - Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing small-molecule therapeutics derived from boron chemistry platform. The company s lead product candidates include tavaborole, an antifungal product candidate in Phase III clinical development for the treatment of onychomycosis; and AN2728, an anti-inflammatory product candidate that completed Phase II clinical trials for the treatment of atopic dermatitis and psoriasis. It also engages in developing GSK2251052, or GSK '052, a systemic antibiotic product candidate in Phase II clinical development for the treatment of infections caused by Gram-negative bacteria; AN8194 for the treatment of an animal health indication; and AN5568, a Phase I human clinical trial product targeting human African trypanosomiasis. The company s clinical pipeline also includes AN2718, a topical antifungal product candidate, which is in Phase I clinical trials for the treatment of onychomycosis and fungal infections of the skin; and AN2898, a topical anti-inflammatory product candidate in the Phase IIa clinical trials for the treatment of atopic dermatitis and psoriasis. It has research, development, and collaboration agreements with GlaxoSmithKline LLC; Eli Lilly and Company; Medicis Pharmaceutical Corporation; and Medicines for Malaria Ventures. The company was formerly known as AnaMax, Inc. and changed its name to Anacor Pharmaceuticals, Inc. in 2002. Anacor Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Palo Alto, California.

<p>Dyax Corp (NASDAQ:DYAX) - Dyax Corp., a biopharmaceutical company, focuses on identification, development, and commercialization of treatments for conditions identified as plasma kallikrein mediated angioedema. The company develops KALBITOR by using its phage display technology for the treatment of acute attacks of HAE. It markets KALBITOR through wholesale and co-exclusive specialty pharmacy arrangements in the United States. The company is also involved in the clinical development of ecallantide for use in the treatment of ACEI-AE; and development of a human monoclonal antibody inhibitor of plasma kallikrein, which is a candidate to prophylactically treat plasma kallikrein mediated angioedemas. In addition, the company, through licensing and funded research program (LFRP), has 18 product candidates in clinical development. Dyax Corp. grants its licensees the rights to use its phage display libraries in connection with their internal therapeutic development programs; performs funded research for various collaborators using its phase display technology to identify, characterize, and optimize antibodies under the funded research program; and grants other biopharmaceutical and pharmaceutical companies non-exclusive licenses to use its core phage display patents to discover and develop biologic compounds under the patent license program. It has a strategic collaboration agreement with Sigma-Tau Rare Diseases S.A. to develop and commercialize ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia; and a strategic partnership with the Novellus Biopharma AG for the development and commercialization of KALBITOR for the treatment of hereditary angioedema and other angioedema indications in Latin America, as well as a strategic partnership with CVie Therapeutics for the development and commercialization of KALBITOR in China, Hong Kong, and Macau. The company was founded in 1989 and is headquartered in Burlington, Massachusetts.</p>

IDACORP Inc (NYSE:IDA) - IDACORP, Inc., through its subsidiary, Idaho Power Company, engages in the generation, transmission, distribution, sale, and purchase of electric energy in the United States. It owns and operates 17 hydroelectric generating plants located in southern Idaho and eastern Oregon, as well as 2 natural gas-fired plants situated in southern Idaho; and owns interests in 3 coal-fired steam electric generating plants located in Wyoming, Nevada, and Oregon. As of December 31, 2011, the company provided electric service to approximately 496,000 general business customers involved in food processing, electronics and general manufacturing, agriculture, forest products, beet sugar refining, and winter recreation. It had a network of approximately 4,828 pole miles of high-voltage transmission lines, 23 step-up transmission substations located at power plants, 24 transmission substations, 10 switching stations, 228 energized distribution substations, and approximately 26,714 pole miles of distribution lines. The company, through its other subsidiaries, invests in housing and other real estate investments in the United States, Puerto Rico, and the United States Virgin Islands. IDACORP, Inc. was founded in 1915 and is headquartered in Boise, Idaho.

<p>Structured Products Corp. 8.0% CorporateBacked Trust Securities Certifi (NYSE:KTH) - Structured Products Corp. 8.0% CorporateBacked Trust Securities Certifi</p>

About WEALTHMAKERS

<p>Wealthmakers Online Predictive Research (WOPR) is a distributed computing system that has hundreds of data feeds (economic, weather, geopolitical, interest rates, energy, equities, currencies, commodities, etc.) feeding into a relational database that searches for patterns and determines how a trading instrument has behaved both before and after specific events have taken place in the past. Only about 25% of stocks display patterns at any given time and only about 1% of stocks exhibit all the necessary conditions on any given day to make a trade. That means that out of 14,000 stocks, only about 140 trades are high probability trades that our system would generate a research report on and disseminate the information to clients. This process eliminates the noise and only tells you which stocks have multiple strategies lining up at the same time, in the same direction, with no conflicting predictions and the fundamental valuation is in-line with the prediction!</p>

Strategies include:

<p>EARNINGS - Most stock price histories show random or unpredictable movements around earnings reports. But some repeat the same pattern quarter after quarter, year after year. Earnings predict probability, price move and length of move before and after all US stock earnings reports.</p>

FRICTION FACTOR - Friction Factor is based on the relationship between the price of a stock and the volume at which it's bought and sold. Normal and abnormal Friction factor patterns can help you time your buying and selling decisions for maximum earnings potential.

<p>GATS - The Global Automated Trading System (GATS) combines neural networks and genetic algorithms to reduce investment risks. GATS selects the highest probability trades in stocks, bonds, options, commodities, currencies and private equities, delivering precise, predictive and profitable data.</p>

GROUP SECTOR - Certain institutions can exert buying or selling pressure over an entire industry group, pushing prices higher. Group Sector identifies stocks that most closely match their group's movement and generate powerful group consensus trading signals to help you profit from the herd mentality.

<p>PATTERN SCANNER - describes the current technical situation in your stock. It displays the technicals, trend conditions and seasonal factors and automatically discovers how that stock has performed in the trading days following the occurrences of the event or combination of events. This technology automatically scans using complex historical queries based on what event is taking place right now in the stock. It then displays the probability, expected return and number of trading days for the expected move.</p>

EVENTS - This technology automatically tracks "Trigger Events" that positively or negatively affect the value of a stock or its perceived value among analysts ranging from price fluctuations to natural disasters and political shifts. The results reveal patterns that can predict market movements.

<p>RegSHO NAKED SHORTS - SEC Regulation SHO mandates that if a clearing agent holds a fail-to-deliver position for 13 consecutive settlement days, it must purchase securities to close out its position, a.k.a. a forced cover. WealthMakers aggregates data from NYSE, AMEX, NASDAQ, OTCBB and PINKSHEETS to track stocks that are about to have forced covers.</p>

SEASONALITY - Seasonality analyzes more than 20 years of data to determine if stocks have a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias.

<p>SQUEEZETRIGGER - Our proprietary database of more than 3,500,000,000 short sale transactions allows us to calculate the exact price at which the total short interest is short in each stock. Squeeze Trigger Alerts let you know exactly when a short squeeze will start and how to trade profitably.</p>

VALUATION - A stock's value is a function of its forecasted earnings per share and forecasted earnings growth, as well as profitability, interest and inflation rates. Valuation use these metrics to determine at what price a stock is undervalued or overvalued, so that you can make investment decisions accordingly.

<p>INSIDER - Significant stock sales or purchases by company "insiders" (officers or directors) can be a predictor of future price movements, up or down. The Insider strategy tracks these actions and correlates them with historical data to give you an investment edge.</p>

DISCLAIMER:

<p>WEALTHMAKERS is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. WEALTHMAKERS has not been compensated by any of the above mentioned companies specifically for this report. Past performance is not indicative of future results. Please visit our web site, www.wealthmakers.com , for complete risks and disclosures. </p>

Contact:

WEALTHMAKERS 1-516-858-1113 tom@wealthmakers.com www.wealthmakers.com

</div>

Contributing Sources

---